B. Riley Wealth Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

B. Riley Wealth Management’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-82	Closed	-$2K	–	797
2015 Q2	$2K	Hold	82	–	–	﹤0.01%	966
2015 Q1	$2K	Hold	82	–	–	﹤0.01%	977
2014 Q4	$1K	Hold	82	–	–	﹤0.01%	993
2014 Q3	$1K	Hold	82	–	–	﹤0.01%	1048
2014 Q2	$1K	Hold	82	–	–	﹤0.01%	1090
2014 Q1	$2K	Buy	+82	New	+$1.7K	﹤0.01%	1023

Other funds holding MRTX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

CCI

Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

B. Riley Wealth Management's MRTX Position: Q3 2015 in Review

B. Riley Wealth Management sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2015, closing a stake of 82 shares — an estimated $2K sold.

B. Riley Wealth Management first reported a position in MRTX in Q1 2014 and held it in 6 quarters. The position peaked at $2K in Q2 2015. 78 funds tracked by Wall St. Rank hold MRTX as of Q3 2015.

B. Riley Wealth Management reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
B. Riley Wealth Management sold 82 Mirati Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $2K.
B. Riley Wealth Management first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2014 and held it in 6 quarters.
B. Riley Wealth Management's Mirati Therapeutics, Inc. Common Stock position peaked at $2K in Q2 2015.
78 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.